Please find attached the Monitoring Agency Report issued by Crisil Ratings Limited for the quarter ended March 31 2026.
VINEETLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Crisil Ratings Limited, the monitoring agency appointed for Vineet Laboratories' Rights Issue, has submitted its report for Q4 FY2026. The Rights Issue (January 2026) raised Rs. 2,996.81 lakhs (net proceeds Rs. 2,921.18 lakhs). As of March 31, 2026, Rs. 1,352.24 lakhs has been utilized out of Rs. 2,996.18 lakhs total, leaving Rs. 1,643.94 lakhs unutilized. Utilization includes: Rs. 284 lakhs for loan repayment (complete), Rs. 33.75 lakhs for Effluent Treatment Plant (of Rs. 270 lakhs), Rs. 293.65 lakhs for new production facility (of Rs. 1,696.35 lakhs), Rs. 670.66 lakhs for General Corporate Purposes (nearly complete), and Rs. 70.18 lakhs for issue expenses (of Rs. 75 lakhs). The report notes a delay: only Rs. 998.06 lakhs was deployed in fiscal 2026 against the planned Rs. 1,654.01 lakhs, primarily because issue proceeds were received in February 2026. The company plans to carry forward unutilized funds to FY2027-28 as per the prospectus.
The unutilized amount of Rs. 1,643.94 lakhs (~55% of raised capital) remains deployed in bank accounts pending deployment. The delay in project execution is attributed to the late receipt of issue proceeds, not a structural problem, but shareholders should monitor the upcoming board meeting where the revised deployment plan will be approved.